Enteroendocrine cells: A review of their role in brain-gut communication

Neurogastroenterology and Motility

Volumn 28, Issue 5, 2016, Pages 620-630

  Latorre, R ^a   Sternini, C ^b   De Giorgio, R ^c   Greenwood Van Meerveld, B ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Afferent neurons; Gut chemosensing; Peptides

Indexed keywords

AMINO ACID RECEPTOR; CHOLECYSTOKININ; G PROTEIN COUPLED RECEPTOR; GLUCAGON LIKE PEPTIDE 1; PEPTIDE YY; GASTROINTESTINAL HORMONE;

BILE SECRETION; BRAIN; CELL DIFFERENTIATION; CELL FUNCTION; CELL STRUCTURE; CELLULAR DISTRIBUTION; ENTEROENDOCRINE CELL; FOOD INTAKE; GASTROINTESTINAL MOTILITY; HOMEOSTASIS; HORMONE RELEASE; INTESTINE; INTESTINE INNERVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; REVIEW; SENSORY NERVE; SENSORY NERVE CELL; SENSORY RECEPTOR; TASTE BUD; VAGUS NERVE; CELL COMMUNICATION; CYTOLOGY; EATING; GASTROINTESTINAL TRACT; HUMAN; NERVE TRACT; PHYSIOLOGY;

BRAIN; CELL COMMUNICATION; EATING; ENTEROENDOCRINE CELLS; GASTROINTESTINAL HORMONES; GASTROINTESTINAL TRACT; HUMANS; NEURAL PATHWAYS;

EID: 84952333567     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/nmo.12754     Document Type: Review

References (99)

1. Rehfeld JF. A centenary of gastrointestinal endocrinology. Horm Metab Res 2004; 36: 735-41.
2. Janssen S, Depoortere I. Nutrient sensing in the gut: new road to therapeutics? Trends Endocrinol Metab 2013; 24: 92-100.
3. Sternini C, Anselmi L, Rozengurt E. Enteroendocrine cells: a site of "taste" in the gastrointestinal chemosensing. Cur Opin Endocri Diabetes Obes 2008; 15: 73-8.
4. Larsson LI, Goltermann N, De Magistris L, Rehfeld JF, Schwarz TW. Somatostatin cell processes as pathways for paracrine secretion. Science 1979; 205: 1393-5.
5. Böttcher G, Sjölund K, Ekblad E, Håkanson R, Schwartz TW, Sundler F. Coexistence of peptide YY and glicentin immunoreactivity in endocrine cells of the gut. Regul Pept 1984; 8: 261-6.
6. Keast JR, Furness JB, Costa M. Distribution of certain peptide-containing nerve fibers and endocrine cells in the gastrointestinal mucosa in five mammalian species. J Comp Neurol 1985; 236: 403-22.
7. Bohòrquez DV, Chandra R, Samsa LA, Vigna S, Liddle RA. Characterization of basal pseudopod-like processes in ileal and colonic PYY cells. J Mol Histol 2011; 42: 3-13.
8. Chandra R, Samsa L, Vigna S, Liddle R. Pseudopod-like basal cell processes in intestinal cholecystokinin cells. Cell Tis Res 2010; 341: 289-97.
9. Dockray GJ. Enteroendocrine cell signalling via the vagus nerve. Curr Opin Pharm 2013; 13: 954-8.
10. Furness JB, Riviera LR, Cho HJ, Bravo DM, Challagan B. The gut as a sensory organ. Nat Rev Gastroenterol Hepatol 2013; 10: 729-40.
11. Psichas A, Reimann F, Gribble FM. Gut chemosensing mechanisms. J Clin Invest 2015; 125: 908-17.
12. Breer H, Eberle J, Frick C, Haid D, Widmayer P. Gastrointestinal chemosensation: chemosensory cells in the alimentary tract. Histochem Cell Biol 2012; 138: 13-24.
13. Mayer EA, Tillisch K, Gupta A. Gut/brain axis and the microbiota. J Clin Invest 2015; 125: 926-38.
14. Dockray GJ. Bayliss-Starling prize lecture. Gastrointestinal hormones and the dialogue between gut and brain. J Physiol 2014; 592: 2927-41.
15. Li HJ, Ray SK, Singh NK, Jhonston B, Leiter AB. Basic helix-loop-helix transcription factors and enteroendocrine cell differentiation. Diabetes Obes Metab 2011; 13: 5-12.
16. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science 1999; 284: 770-6.
17. Höfer D, Asan E, Drenckhahn D. Chemosensory perception in the gut. News Physiol Sci 1999; 14: 18-23.
18. Gribble FM, Reimann F. Enteroendocrine cells: chemosensors in the intestinal epithelium. Annu Rev Physiol 2016; 78: 3.1-3.23.
19. Bohòrquez DV, Samsa LA, Roholt A, Medicetty S, Chandra R, Liddle RA. An enteroendocrine cell-enteric glia connection revealed by 3D electron microscopy. PLoS ONE 2014; 9: e89881.
20. Bohórquez DV, Shaid RA, Erdmann A, Kreger AM, Wang Y, Calakos N, Wang F, Liddle RA. Neuroephitelia circuit formed by innervation of sensory enteroendocrine cells. J Clin Invest 2015; 125: 782-6.
21. Egerod KL, Engelstoft MS, Grunddal KV, Nøhr MK, Secher A, Sakata I, Pedersen J, Windeløv JA et al. A major lineage of enteroendocrine cells coexpress CCK, secretin, GIP, GLP-1, PYY, and neurotensin but not somatostatin. Endocrinology 2012; 153: 5782-95.
22. Habib AM, Richards P, Cairns LS, Rogers GJ, Bannon CA, Parker HE, Morley TC, Yeo GS et al. Overlap of endocrine hormone expression in the mouse intestine revealed by transcriptional profiling and flow cytometry. Endocrynology 2012; 153: 3054-65.
23. Cho H-J, Kosari S, Hunne B, Callaghan B, Rivera LR, Bravo DM, Furness JB. Differences in hormone localisation patterns of K and L type enteroendocrine cells in the mouse and pig small intestine and colon. Cell Tissue Res 2015; 359: 693-8.
24. Dockray GJ, Varro A, Dimaline R. Gastric endocrine cells: gene expression, processing, and targeting of active products. Physiol Rev 1996; 76: 767-98.
25. Dockray GJ. The gut endocrine system and its control. Exp Physiol 1994; 79: 607-34.
26. Kending DM, Grider JR. Serotonin and colonic motility. Neurogastroenterol Motil 2015; 27: 899-905.
27. Gershon MD. 5-Hydroxytryptamine (serotonin) in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes 2013; 20: 14-21.
28. Keating DJ, Spencer NJ. Release of 5-Hydroxytryptamine from the mucosa is not required for the generation or propagation of colonic migrating motor complexes. Gastroenterology 2010; 138: 659-70.
29. Spencer NJ, Nicholas SJ, Robinson L, Kyloh M, Flack N, Brookes SJ, Zagorodnyuk V, Keating DJ. Mechanisms of underlying distension-evoked peristalsis in guinea pig distal colon: is there a role for enterochromaffin cells? Am J Physiol Gastrointest Liver Physiol 2011; 301: G519-27.
30. Mawe GM, Hoffman JM. Serotonin signaling in the gut-functions, dysfunctions and therapeutic targets. Nat Rev Gastroenterol Hepatol 2013; 10: 473-86.
31. Klok MD, Jakobsdottir S, Drent ML. The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obes Rev 2007; 8: 21-34.
32. Cummings DE, Overduin J. Gastrointestinal regulation of food intake. J Clin Invest 2007; 117: 13-23.
33. Sakata I, Nakamura K, Yamazaki M, Matsubara M, Hayashi Y, Kangawa K, Sakai T. Ghrelin-producing cells exist as two types of cells, closed- and opened type cells, in the rat gastrointestinal tract. Peptides 2002; 23: 531-6.
34. Holst JJ. Incretin hormones and the satiation signal. Int J Obes (Lond) 2013; 37: 1161-8.
35. Sigalet DL, Wallace LE, Holst JJ, Martin GR, Kaji T, Tanaka H, Sharkey KA. Enteric neural pathways mediate the anti-inflammatory actions of glucagon-like peptide 2. Am J Physiol Gastrointest Liver Physiol 2007; 293: G211-21.
36. Rowland KJ, Brubaker PL. The "cryptic" mechanism of action of glucagon-like peptide-2. Am J Physiol Gastrointest Liver Physiol 2011; 301: G1-8.
37. Hsieh J, Longuet C, Maida A, Bahrami J, Xu E, Baker CL, Brubaker PL, Drucker DJ et al. Glucagon-like peptide-2 increase intestinal lipid absorption and chylomicron production via CD36. Gastroenterology 2009; 137: 997-1005.
38. Batterham RL, Cohen MA, Ellis SM, Le Roux CW, Withers DJ, Frost GS, Ghatei MA, Bloom SR. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 2003; 349: 941-8.
39. Halatchev IG, Cone RD. Peripheral administration of PYY(3-36) produces conditioned taste aversion in mice. Cell Metab 2005; 1: 159-68.
40. Spiller RC, Trotman IF, Higgins BE, Ghetei MA, Grimble GK, Lee YC, Bloom SR, Misiewicz JJ et al. The ileal brake-inhibition of jejunal motility after ileal fat perfusion in man. Gut 1984; 25: 365-74.
41. Giralt M, Vergara P. Glucagonlike peptide-1 (GLP-1) participation in ileal brake induced by intraluminal peptones in rat. Dig Dis Sci 1999; 44: 322-9.
42. Van Citters GW, Lin HC. Ileal brake: neuropeptidergic control of intestinal transit. Curr Gastroenterol Rep 2006; 8: 367-73.
43. Daniel H, Zietek T. Taste and move: glucose and peptide transporters in the gastrointestinal tract. Exp Physiol 2015; 100: 1441-50. doi:10.1113/EP085029.
44. Dockray GJ. Making sense of gut contents. Scand J Gastroenterol 2003; 38: 451-5.
45. Janssen S, Laermans J, Verhulst PJ, Thijs T, Tack J, Depoortere I. Bitter taste receptors and α-gustducin regulate the secretion of ghrelin with functional effects on food intake and gastric emptying. Proc Natl Acad Sci USA 2011; 108: 2094-9.
46. Hao S, Sternini C, Raybould HE. Role of CCK1 and Y2 receptors in activation of hindbrain neurons induced by intragastric administration of bitter taste receptor ligands. Am J Physiol Regul Integr Comp Physiol 2008; 294: 33-8.
47. Hao S, Dulake M, Espero E, Sternini C, Raybould HE, Rinaman L. Central Fos expression and conditioned flavor avoidance in rats following intragastric administration of bitter taste receptor ligand. Am J Physiol Regul Integr Comp Physiol 2009; 296: R528-36.
48. Glendinning JI, Yiin YM, Ackroff K, Sclafani A. Intragastric infusion of denatonium conditions flavor aversion and delays gastric emptying in rodents. Physiol Behav 2008; 93: 757-65.
49. Hagbom M, Istrate C, Engblom D, Karlsson T, Rodriguez-Diaz J, Buesa J, Taylor JA, Loitto VM et al. Rotavirus Stimulates Release of Serotonin (5-HT) from human enterochromaffin cells and activates brain structures involved in nausea and vomiting. PLoS Pathol 2011; 7: e1002115.
50. Laffitte A, Neiers F, Briand L. Functional roles of the sweet taste receptor in oral and extraoral tissues. Curr Opin Nutr Metab Care 2014; 17: 379-85.
51. Behrens M, Meyerhof W. Oral and extraoral bitter taste receptors. Results Probl Cell Differ 2010; 52: 87-99.
52. Rozengurt N, Wu SV, Chen MC, Huang C, Sternini S, Rozengurt E. Colocalization of the alpha-subunit of gustducin with PYY and GLP-1 in L cells of human colon. Am J Physiol Gastrointest Liver Physiol 2006; 291: G792-802.
53. +-glucose cotransporter. Proc Natl Acad Sci USA 2007; 104: 15075-80.
54. Vegezzi G, Anselmi L, Huynh J, Barocelli E, Rozengurt E, Raybould H, Sternini C. Diet-induced regulation of bitter taste receptor subtypes in the mouse gastrointestinal tract. PLoS ONE 2014; 9: e107732.
55. Li X, Staszewski L, Xu H, Durick K, Zoller M, Adler E. Human receptors for sweet and umami taste. Proc Natl Acad Sci USA 2002; 99: 4692-6.
56. Nelson G, Hoon MA, Chandrashekar J, Zhang Y, Ryba NJP, Zuker CS. Mammalian sweet taste receptors. Cell 2001; 106: 381-90.
57. Depoortere I. Taste receptors in the gut tune the release of peptides in response to nutrients. Peptides 2015; 66: 9-12.
58. Bachmanov AA, Beauchamp GK. Taste receptor genes. Annu Rev Nutr 2007; 27: 389-414.
59. Meyerhof W, Batram C, Kuhn C, Brockhoff A, Chudoba E, Bufe B, Appendino G, Behrens M. The molecular receptive ranges of human TAS2R bitter taste receptors. Chem Senses 2010; 35: 157-70.
60. MacLeod RJ. CaSR function in the intestine: hormone secretion, electrolyte absorption and secretion, paracrine non-canonical Wnt signaling and colonic crypt cell proliferation. Best Pract Res Clin Endocrinol Metab 2013; 27: 385-402.
61. Haid DC, Jordan-Biegger C, Widmayer P, Breer H. Receptors responsive to protein breakdown products in g-cells and d-cells of mouse, swine and human. Front Physiol 2012; 3: 1-15. doi:10.3389/fphys.2012.00065.
62. Edfalk S, Steneberg P, Edlund H. Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion. Diabetes 2008; 57: 2280-7.
63. Janssen S, Laermans J, Iwakura H, Tack J, Depoortere I. Sensing of fatty acids for octanoylation of ghrelin involves a gustatory G-protein. PLoS ONE 2012; 7: 7e40168.
64. Hirasawa A, Tsumaya K, Awaji T, Katsuma S, Adachi T, Yamada M, Sugimoto Y, Miyazaki S et al. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med 2005; 11: 90-4.
65. Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, Muir AI, Wigglesworth MJ et al. The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem 2003; 278: 11312-9.
66. Karaki S, Tazoe H, Hayashi H, Kashiwabara H, Tooyama K, Suzuki Y, Kuwahara A. Expression of the short-chain fatty acid receptor, GPR43, in the human colon. J Mol Histol 2008; 39: 135-42.
67. Tazoe H, Otomo Y, Karaki S, Kato I, Fukami Y, Terasaki M, Kuwahara A. Expression of short-chain fatty acid receptor GPR41 in the human colon. Biomed Res 2009; 30: 149-56.
68. Tolhurst G, Heffron H, Lam YS, Parker HE, Habib AM, Diakogiannaki E, Cameron J, Grosse J et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G- protein-coupled receptor FFAR2. Diabetes 2012; 61: 364-71.
69. Samuel BS, Shaito A, Motoike T, Rey FE, Backhed F, Manchester JK, Hammer RE, Williams SC et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci USA 2008; 105: 16767-72.
70. Cani PD, Everard A, Duparc T. Gut microbiota, enteroendocrine functions and metabolism. Curr Opin Pharmacol 2013; 13: 935-40.
71. Carabotti M, Scirocco A, Maselli MA, Severi C. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol 2015; 28: 203-9.
72. Nøhr MK, Pedersen MH, Gille A, Egerod KL, Engelstoft MS, Husted AS, Sichlau RM, Grunddal KV et al. GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs. FFAR3 in enteric neurons and FFAR2 in enteric leukocytes. Endocrinology 2013; 154: 3552-64.
73. Mayer EA. Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci 2011; 12: 453-66. doi:10.1038/nrn3071.
74. Mayer EA, Tillisch K. The brain-gut axis in abdominal pain syndromes. Ann Rev Med 2011; 62: 381-96.
75. Beyak M, Bulmer DCE, Jiang W, Keating C, Rong W, Grundy D. Extrinsic sensory afferent nerves innervating the gastrointestinal tract. In: Johnson LR, Barrett KE, Ghishan FK, Merchant JL, Said HM, Wood JD, eds. Physiology of the Gastrointestinal Tract, 4th edn. San Diego, CA: Elsevier, 2006: 685-726.
76. Raybould HE. Gut Chemosensing: interaction between gut endocrine cells and visceral afferents. Auton Neurosci 2010; 153: 41-6.
77. Dockray GJ. Luminal sensing in the gut: an overview. J Physiol Pharmacol 2003; 54: 9-17.
78. Whited KL, Thao D, Lloyd KC, Kopin AS, Raybould HE. Targeted distruption of the murine CCK1 receptor gene reduces intestinal lipid-induced feedback inhibition of gastric function. Am J Physiol Gastrointest Liver Physiol 2006; 291: G156-62.
79. Peters JH, Simasko SM, Ritter RC. Modulation of vagal afferent excitation and reduction of food intake by leptin and cholecystokinin. Physiol Behav 2006; 89: 477-85.
80. Buyse M, OvesjÖ ML, Goïo H, Guilmeau S, Péranzi G, Moizo L, Walker F, Lewin MJ et al. Expression and regulation of leptin receptor protein in afferent and efferent neurons of the vagus nerve. Eur J Neurosc 2001; 14: 64-72.
81. Cheung GW, Kokorovic A, Lam CK, Chari M, Lam TK. Intestinal cholecystokinin controls glucose production through a neuronal network. Cell Metab 2009; 10: 99-109.
82. Rasmussen BA, Breen DM, Luo P, Cheung GWC, Yang CS, Sun B, Kokorovic A, Rong W et al. Duodenal activation od cAMP-dependent protein kinase induces vagal afferent firing and lower glucose production in rats. Gastroenterology 2012; 142: 834-43 e3.
83. Holzer P, Reichmann F, Farzi A. Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis. Neuropeptides 2012; 46: 261-74.
84. Ekblad E, Sundler F. Distribution of pancreatic polypeptide and peptide YY. Peptides 2002; 23: 251-61.
85. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 2002; 418: 650-4.
86. 3-36-induced stimulation of intestinal feedback. Endocrinology 2007; 148: 4695-703.
87. Abbott CR, Monteiro M, Small CJ, Sajedi A, Smith KL, Parkinson JR, Ghatei MA, Bloom SR. The inhibitory effects of peripheral administration of peptide (3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res 2005; 1044: 127-31.
88. Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev 2007; 87: 1409-39.
89. I˙meryüz N, Yeğen BC, Bozkurt A, Coşkun T, Villanueva-Peñacarrillo ML, Ulusoy NB. Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms. Am J Physiol 1997; 273: G920-7.
90. Nadkarni P, Chepurny OG, Holz GG. Regulation of glucose homeostasis by GLP-1. Prog Mol Biol Transl Sci 2014; 121: 23-65.
91. Holst JJ, Deacon CF. Glucagone-like peptide-1 mediates the therapeutic actions of PP-IV inhibitors. Diabetologia 2005; 48: 612-5.
92. Bohòrquez DV, Liddle RA. Axon-like processes in enteroendocrine cells: characteristics and potential targets. Clin Transl Sci 2011; 4: 387-91.
93. Meloni AR, De Young MB, Lowe C, Parkes DG. GLP-1 receptor activated insulin secretion from pancreatic β-cell: mechanism and glucose dependence. Diabetes Obes Metab 2013; 15: 15-27.
94. Holst JJ. Enteroendocrine secretion of gut hormones in diabetes, obesity and after bariatric surgery. Curr Opin Pharmacol 2013; 13: 983-8.
95. De Mello AH, Prá M, Cardoso LC, De Bona Schraiber R, Rezin GT. Incretin-based therapies for obesity treatment. Metabolism 2015; pii: S0026-0495(15)00155-9. doi: 10.1016/j.metabol.2015.05.012.
96. Park JH, Rhee P-L, Kim G, Lee JH, Kim Y-H, Kim JJ, Rhee JC, Song SY. Enteroendocrine cell counts correlate with visceral hypersensitivity in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil 2006; 18: 539-46.
97. Greenwood-Van Meerveld B, Mohammadi E, Tyler K, Pietra C, Bee LA, Dickenson A. Synergistic effect of 5-hydroxytryptamine 3 and neurokinin 1 receptor antagonism in rodent models of somatic and visceral pain. J Pharmacol Exp Ther 2014; 351: 146-52.
98. 4 receptor partial agonist, YKP10811, on visceral hypersensitivity in rats triggered by stress and inflammation. Neurogastrenterol Motil 2014; 26: 1761-70.
99. Keszthelyi D, Troost FJ, Jonkers DM, Van Eijk HM, Dekker J, Buurman WA, Masclee AAM. Visceral hypersensitivity in irritable bowel syndrome: evidence for involvement of serotonin metabolism- preliminary study. Neurogastroenterol Motil 2015; 27: 1127-37.